been shown to trigger a broad range of changes in gene expression in plants and in non-plant multicellular organisms (1) (2) (3) (4) (5) . Only plants and some bacteria are able to absorb sunlight directly and plants have developed sophisticated mechanisms to sense light conditions and adjust their developmental programs accordingly (6) . Many components of the light signaling cascades have been revealed over the years, mostly by genetic approaches. Among them, COP1 (constitutive photomorphogenic protein 1) was one of the first cloned and is one of the most extensively studied. COP1 is a RING-finger protein; it was first described in
Arabidopsis thaliana (7).
COP1 in plants
It has been established that Arabidopsis thaliana COP1 (AtCOP1) functions as an essential negative regulator of light-mediated plant development, as evidenced by cop1 mutant seedlings undergoing photomorphogenic development even in the absence of light, and plants with cop1 null alleles never survive to the adult stage (7). AtCOP1, an E3 ubiquitin ligase, is essential for the proteasome-dependent degradation of a number of bZIPtype transcription factors, such as HY5, HYH, LAF1 and HFR1 (8) . Genome-wide microarray analysis has demonstrated that AtCOP1 regulates most, if not all, of the lightresponsive genes under various light conditions (1) . AtCOP1 functions as a crucial developmental switch through targeting key transcription factors for degradation, thereby controlling light-responsive gene expression and photomorphogenic development (9, 10) .
In photosynthetizing cells, the subcellular distribution of AtCOP1 is adjusted according to the light conditions. In darkness, AtCOP1 is mainly localized to the nucleus, where it presumably targets photomorphogenesis-promoting transcription factors for ubiquitination and degradation, thereby repressing the expression of photomorphogenesis genes. When cells are exposed to light, there are drastic reductions in AtCOP1 levels in the nucleus, allowing nuclear-localized transcription factors to re-accumulate. These transcription factors activate the transcription of downstream genes required for plants to undergo photomorphogenesis (11,12).
COP1 in non-plant organisms
Although, COP1 also exists in non-plant multicellular organisms, its function is less understood among vertebrates, COP1 is well conserved among fish, amphibians, birds and mammals, it is apparent that, unlike plants, animals do not undergo photomorphogenesis.
Several initial studies have implied that animal COP1 may have adopted roles in tumorigenesis and stress response, although its biochemical activities and some of the signaling elements it interacts with appear to be conserved between plants and animals (13).
Structural and functional analogy between AtCOP1 and mammalian COP1
Mammalian COP1 (MmCOP1), as human COP1 (huCOP1), is located at chromosome 1 and exhibits a high degree of sequence conservation and domain organization with AtCOP1
( Fig. 1) , suggesting the possibility of functional conservation (13) . Both MmCOP1 and AtCOP1 contain three conserved structural domains: a RING finger at the amino terminus, a coiled-coil domain in the middle, and a carboxyl-terminal WD40 repeat domain (11, (14) (15) (16) . Earlier studies suggested that COP1 acts primarily as a homodimer, and probably dimerizes through the coiled-coil domain (8, 10, 13, 17) . The coiled-coil region and the seven WD40 motifs region comprise potential interaction domains for other protein partners.
The discrete nuclear pattern of huCOP1 depends on the presence of these domains and is compatible with distribution to specific subnuclear compartments, as has been described for other RING proteins, such as promyelocytic leukemia protein (PML) (18) . The RING-finger and the coiled-coil domains can function independently as light-responsive modules mediating the light-controlled nucleocytoplasmic partitioning of COP1. The seven C-terminal WD40 domains function as an autonomous repressor module since the overexpression of mutant COP1 with intact WD40 repeats is able to suppress photomorphogenic development (8) .
As compared with AtCOP1, MmCOP1 has an N-terminal extension that may be responsible for targeting COP1 to the nuclear envelope (NE) part of the nucleus. COP1 is predominantly localized in the nucleus, but a small amount may also be present in the cytosol.
COP1 shuttles between the nucleus and the cytoplasm and forms subnuclear speckles in both plants and mammals. MmCOP1 and AtCOP1 utilize different nuclear import and nuclear export signals (NIS and NES) located in distinct regions for their nucleocytoplasmic shuttling and subnuclear localizations (11, 13) . proteins contain three structural domains: a RING finger, followed by a coiled-coil domain and seven WD40 repeats at the C-terminus. The AtCOP1 RING finger interacts with CIP8 and COP10. COP1 utilizes the coiled-coil domain for self-dimerization in both plants and mammals. In addition, the AtCOP1 coiled-coil domain interacts with SPA, CIP1, CIP4 and CIP7, while the coiled-coil domain of MmCOP1 has been implicated in binding to DET1. COP1 interacts through its WD40 repeats with HY5, HYH, STO, STH, HFR1, cry1, cry2, phyA and phyB in plants and with c-Jun in mammals. Other COP1-interacting factors whose interacting domains have not been mapped include LAF1 in Arabidopsis, and p53 and the major vault protein (MVP) in mammals (11).
Function of mammalian COP1
MmCOP1, like AtCOP1, is involved in ubiquitination and is itself a substrate of its own ubiquitination activity (11, 13) . COP1 ubiquitination substrates have been identified in mammals: c-Jun and p53 (17, 19) . COP1-mediated p53 degradation is an important regulatory mechanism for the p53 function in the cell: depletion of COP1 leads to p53 accumulation and cell-cycle arrest, while the overexpression of COP1 inhibits p53-dependent apoptosis. Overexpression of huCOP1 in mammalian cells downregulates c-Jun-dependent transcription and expression of the AP-1 target genes, urokinases and matrix metalloproteinases (13, 20) . It has been suggested that MmCOP1 functions as an adaptor protein recruiting c-Jun to an E3 complex, possibly containing DET1, DDB1, cullin4A and Roc1, through direct interaction with DET1 ( Fig. 2 ) (17) . MmCOP1 binds to c-Jun through a conserved motif shared by the plant bZIP family COP1 substrates HY5 and HYH, and also represses c-Jun-mediated AP-1 transcription without affecting c-Jun protein levels (11). . COP1 is able to target the bZIP transcription factors HY5 (in Arabidopsis) and c-Jun (in human) for ubiquitination and proteasome-mediated degradation (11).
p53 regulation in keratinocytes and in the epidermis
p53, a nuclear phosphoprotein first identified by Lane and Crawford in 1979, is encoded by a tumor suppressor gene on the short arm of chromosome 17 (21) . It binds to DNA as a tetramer and activates the transcription of many genes involved in cell differentiation, proliferation, induction of DNA repair pathways and cell death (5, 22, 23) .
The loss of p53 function by mechanisms such as mutations or binding to viral proteins increases the risk of development for certain types of cancers. p53 is mutated or deleted in more than 50% of human tumors and in most skin carcinomas (22, (24) (25) (26) (27) (28) . As regards UVinduced skin tumors, p53 is considered to play an important role in their pathogenesis (29, 30) .
In normal unstressed cells, p53 is a very unstable protein with a half-life ranging from 5 to 30 min. Its short half-life is linked to polyubiquitination and proteasome-dependent degradation, while the protein is positively regulated through a succession of posttranslational modifications including phosphorylation and acetylation (25, 31, 32) . A hallmark of many cellular stress pathways, such as DNA damage, telomere shortening and oncogene activation, is the rapid stabilization of p53 via blocking its degradation (33) . The p53 protein level is increased and stabilized in both murine and human keratinocytes when treated with UVB light (34) . Its increased level is induced rapidly by UV irradiation as a result of posttranslational protein stabilization, although the translocation of cytoplasmic p53 to the nucleus may also contribute to protein stabilization (35) . p53 accumulates intracellularly up to readily detectable levels, arresting cells in the G1 phase, until cellular damage is fully repaired or the cell-death pathway is initiated (36).
In normal human skin, p53 is generally not detected in the epidermis, which has been attributed to its relatively short half-life (33, (37) (38) (39) . p53 is the key UV-responsive gene in skin, whose mutation is thought to initiate carcinogenesis, but its role in the control of keratinocyte proliferation and differentiation is less clear (26, 34) . Epidermal keratinocytes are most susceptible to damage from UV light, because they are close to the skin surface. The epidermis is a stratified epithelium in which the basal layer contains stem cells and transient amplifying cells the latter that divide continuously to supply cells that enter the differentiating program and move up the epidermis (40-42).
E3 ubiquitin ligases and p53 regulation
p53 expression has been shown to be controlled by a plethora of upstream regulatory proteins ( Fig. 3 ) (28, 43) . p53 is tightly regulated: the main antagonists of human tumor suppressor p53 are Mdm2, Pirh2 and huCOP1 E3 ubiquitin ligases. These proteins directly promote p53 ubiquitination and its proteasome-dependent degradation. The proteasomes operate both in the nucleus and in the cytoplasm. Mdm2 interacts physically with and ubiquitinates p53, leading to its degradation in the cytosolic 26S proteasome, but it has also been demonstrated that p53 degradation may occur in either the cytosolic or the nuclear proteasomes and does not require nuclear export (44, 45) . In addition to Mdm2, Pirh2 and COP1 have been shown to impart specificity toward p53. The nuclear monoubiquitination of p53 by Mdm2 leads to the accumulation of p53. Following monoubiquitination, p53 may remain in the nucleus to be polyubiquitinated by Mdm2, Pirh2, COP1 or a complex of these proteins (43, 46, 47) . Alternatively, p53 monoubiquitination by Mdm2 could promote the cytosolic accumulation of p53, where it is further polyubiquitinated by Mdm2, Pirh2, COP1 or a complex of these proteins, and degraded by cytosolic 26S proteasomes. It has been demonstrated in U2OS osteosarcoma cells that COP1 promotes p53 turnover independently of Mdm2 or Pirh2 (19).
Kinetics of p53 expression during keratinocyte differentiation
Keratinocytes undergo a complex developmental program as they progress from the basal to the spinous, granular and finally the cornified layer of the epidermis (Fig. 4) . p53 is expressed at low levels in UV-unexposed skin and is activated during the exit from the proliferative state, resulting in inhibition of cell division and stimulation of differentiation (48) . Later, as the keratinocytes progress in the differentiation associated the cell death program, they become insensitive to p53-induced apoptosis (39, 48) . UV light induces p53
in the proliferative compartment of the basal layer cells (49) , resulting in cell cycle arrest and apoptosis, which protects from cancer induction (22, 34) . When p53 is inhibited in the basal layer by a negative regulator protein (48), such as Mdm2, this leads to decreased differentiation and increased proliferation. Increased apoptosis is an indirect effect of the mechanisms that maintain homeostasis. Proliferation and differentiation are compartmentalized within the human epidermis.
Keratinocytes proliferate in the basal layers perhaps as long as they are in contact with the extracellular matrix at and around the basement membrane (40) . Proliferation is therefore controlled by integrins, the surface molecules that mediate cell adhesion. As the specific integrin functions are disrupted, keratinocytes migrate into the suprabasal layers, initiate terminal differentiation, enlarge, and ultimately produce the cornified envelope that sheds from the surface of the skin (41, 50, 51 
COP1 in human tumors
As COP1 is a critical negative regulator of p53 in normal and cancer cell lines (19) , its role has been investigated in detail in human cancers . The overexpression of COP1 was detected predominantly, but not exclusively, in wild-type p53-containing cancers, such as ovarian tumors, breast adenocarcinomas (59) and hepatocellular carcinomas (60),
indicating that one of the major roles of COP1 is to repress p53-dependent tumor suppression. 
AIMS
Taken together, these data suggest that huCOP1 is involved in the orchestrating of several cellular processes, and contributes to cellular stress response after genotoxic stress.
The overexpression of COP1 in some human tumors suggests its possible in tumorigenesis.
In human keratinocytes, however, that are permanently exposed to many environmental factors, huCOP1 and its possible functions have not yet been investigated.
Therefore, we aimed
• to characterize huCOP1 is expression in cultured human keratinocytes and in human epidermis, • to investigate the effect of UVB on huCOP1 expression in human cultured keratinocytes and human epidermis, • to elucidate the COP1-p53 interaction in human keratinocytes
• to determine the effect of UVB in COP1-silenced human keratinocytes together with UVB irradiation • to characterize changes in COP1 expression during keratinocyte differentiation.
MATERIALS AND METHODS

Human tissue samples. Culturing of normal human keratinocytes and HaCaT keratinocytes
Human tissue samples from various human organs were taken from patients who underwent different operations at the Department of Surgery, University of Szeged. Only noninvolved, healthy tissues were used for RNA isolation. All tissue samples were taken as described previously (67) Germany), at 37 °C in a 5% CO 2 atmosphere.
Immunocytochemistry, immunohistochemistry and immunofluorescence staining
The Nonspecific staining was prevented by preincubation with 0.5% bovine serum albumin diluted in Tris-buffered saline (Sigma) containing 0.1% Triton-X (Reanal) for 30 mins at room temperature in a humid chamber. The slides were then incubated overnight at 4 °C in a humid chamber with the primary antibody; rabbit polyclonal anti-human COP1 antibody (Bethyl, Montgomery, TX, USA) was applied at 1:5000 dilution, and rabbit IgG (NeoMarkers) was used for isotype control staining. Slides were then incubated with a biotinylated secondary antibody (anti-rabbit IgG) at 1:800 dilution for 1 h at room temperature, followed by incubation with horse radish peroxidase-conjugated streptavidin for 1 h at room temperature (both from Vectastain ABC Kit; Vector, Burlingame, CA), and at the end of the staining procedure peroxidase activity was detected by using 3,3-amino-9
ethylcarbazole (Sigma) as substrate. Slides were counterstained with hematoxylin (Sigma).
Tissue staining was visualized with a Zeiss Axio Imager microscope and photographed with a PixeLINK digital camera.
The immunofluorescence staining was performed as described above in connetion with the immunohistochemical staining until the incubation with the primary antibody. The slides were then incubated at 4 °C overnight in a humid chamber with the primary antibody;
rabbit polyclonal anti-human COP1 antibody (Bethyl, Montgomery, TX, USA) was applied at 1:4000 dilution; control slides were incubated with a mixture of COP1 Blocking peptide (Bethyl, Montgomery, USA) and rabbit polyclonal anti-human COP1 antibody (Bethyl) in a ratio of 3:1. After a rinse in TBS-Triton-X, sections were incubated with Alexa Fluor 488-labeled secondary anti-rabbit antibody (Invitrogen, Carlsbad, CA, USA) (dilution 1:500) for 3 hs, and were then stained with DAPI to detect the nuclei. For detection and analysis, Tissue
Facs (Tissue Gnostics, Vienna, Austria) were used
Constructs
The pSUPER vector system (Oligoengine, Seattle, WA, USA) was used for the transient expression of short interfering RNAs (siRNAs) (61). Fifty-three-nt-long oligonucleotides of COP1
5'AGCTTcttgatttggccaatgtcaTTCAAGAGAtgacattggccaaatcaagttC3' (sense) and COP1
5'AgaactaaaccggttacagtAAGTTCTCTactgtaaccggtttagttcaaGAGCT3' (antisense) were cloned into the pSuperior.puro vector downstream of the H1 promoter.
Nucleofection
For silencing the expression of the COP1 gene, 7-8 x 10 5 cells were transiently transfected with a COP1 siRNA producing construct (siCOP1), and another group of cells received the empty pSUPER vector (Sp). DNA for transfection was purified with the Qiagen Plasmid Mini Kit (Qiagen, Hilden, Germany). Transfection was carried out by nucleofection (Amaxa, Cologne, Germany), and the Human Keratinocyte Kit (VPD-1002; Amaxa) was used for the nucleofection of keratinocytes (62).
Nucleofection was carried out as follows: cultured keratinocytes were trypsinized for 10 min at room temperature, 1 ml FBS was then added and the cells were centrifuged for 10 min at 1000 g. The keratinocytes were next resuspended in 100 µl of Keratinocyte Nucleofector Solution (Amaxa, Cologne, Germany) and 2 µg of DNA was added. The mixture was transferred into an electroporation cuvette and placed into the nucleofector device (Amaxa, Cologne, Germany). Immediately after nucleofection, the keratinocyte suspension was transferred into 6-wellplates, containing 2 ml of prewarmed keratinocyte medium. The culture medium was changed after 48 h.
The transfection efficacy was determined by analyzing the expression of green fluorescent protein (GFP) with a FACScalibur flow cytometer (Becton Dickinson, San Jose, CA, USA) and CellQuest software (Becton Dickinson) and the mean fluorescence intensity of the expressing construct was measured. The average efficacy of transfection was ~60 %.
UVB irradiation (FS20 lamp, excimer laser)
An FS20 lamp (Westinghouse, Pittsburgh, PA, USA) was used as a radiation source for UVB; this instrument emits radiation of wavelength ranging between 250 and 400 nm, peaking at 290 nm (37, 63, 64) . Our radiometry system was an Optronic OL754 spectroradiometer, and for calibration we used an OL752-12D2 lamp. To determine the highest nonlethal dose of UVB, we irradiated keratinocytes with 0, 10, 20, 40 and 60 mJ/cm 2 UVB light, and the viability of the treated cells was analyzed by MTT assay 24 and 48 hs after irradiation. The 40 mJ/cm 2 found to be the highest nonlethal UVB dose was therefore used in subsequent experiments. For irradiation, the medium was removed, 500 µl PBS was added and keratinocytes were irradiated with 10, 20 or 40 mJ/cm 2 UVB. After irradiation, 2 ml of serum-free keratinocyte medium was added to the cells. Samples for mRNA expression experiments were collected 12 hs after irradiation, while samples for protein expression experiments were collected 24 hs after irradiation.
The 308 nm excimer laser, a coherent monochromatic pulse-mode UVB XeCl laser was utilized for human skin irradiation (63) . The minimal erythema dose (MED) was determined with increasing doses of 308 nm UVB, and 2 MED was used for irradiation on a non-sun-exposed area of the body in subsequent experiments. Skin biopsies (6 mm) were taken from irradiated and non-irradiated skin 24 and 48 hs after irradiation with the patients's informed consent and the approval of the local ethics committee. 
Reverse transcription and real-time RT-PCR
Western blot analysis
Cells were washed twice with PBS, and protein was extracted by resuspending the cells in a solution containing 12.5% 0.5 mM Tris (pH 6.8), 2.5% 200 mM EDTA, 15% 10% SDS, 70% H 2 O, 10 µl of protease inhibitor and 50 µl of ß-mercaptoethanol per ml (all chemicals were obtained from Sigma-Aldrich) 24 h after UVB irradiation. Protein lysates were incubated for 5 min on ice and, after a 30-sec hard vortexing, cell debris was removed by centrifugation at 10 000 g for 10 min at 4 °C. In order to verify the equivalent loading of proteins in the wells, the following procedure was carried out: based on the OD280-measured density, the protein concentration of each sample was calculated and the samples were then run on 10% sodium dodecylsulfate-polyacrylamide gel (SDS-PAGE). The gels were stained with Coomassie Brillant Blue (CBB, Sigma-Aldrich), dried and scanned, and all loaded lanes were analyzed by densitometry. The amounts of the loaded protein samples were further corrected and checked again on SDS-PAGE (66).
For western-blot analysis, equal amounts of proteins were run on SDS-PAGE and then transferred to nitrocellulose membrane (Bio-Rad Laboratories, Hercules, CA, USA).
Membranes were blocked by incubation in Tris-buffered saline (150 mM NaCl, 25 mM Tris, 
RESULTS
COP1 expression and subcellular localization in cultured normal human keratinocytes and HaCaT cells
Only limited information is available on COP1 expression in normal human tissue samples, and we therefore set out to determine COP1 expression in a set of RNA samples isolated from various human organs. We were especially interested in whether COP1 was expressed in the epidermis. We also demonstrated by RT-PCR and western blot hybridization assays that normal human cultured keratinocytes express COP1 mRNA and protein (Fig. 6 ). COP1 mRNA was We next determined the subcellular localization of COP1 protein in cultured normal human keratinocytes. COP1 protein was detected both in the cytoplasm as well as in the nucleus in unstressed keratinocytes compared to control cells incubating with blocking peptid before staining. The bulk of the immunofluorescence staining of COP1 was restricted to the nucleus, and only mild positivity was visible in the cytoplasm (Fig. 7) . To measure the kinetic changes in COP1 mRNA expression, keratinocytes were harvested at various time points (0, 6, 12 and 24 hs) after exposure to 40 mJ/cm 2 UVB (n=3) and the COP1 mRNA expression was determined by real-time RT-PCR. The COP1 mRNA levels started to decline within 6 h after UVB exposure, were at an almost undetectable level after 12 hs, and then slowly increased, approaching the normal value at 24 h (Fig. 9) .
UVB irradiation decreases the COP1 protein level in keratinocytes.
We determined the abundance of COP1 and p53 proteins in keratinocytes (n=6) at various time-points (0, 6, 12
and 24 hs) after irradiation with 40 mJ/cm 2 UVB. The UVB-induced a dose-dependent decreases in COP1 protein are shown in Fig. 10 . In contrast with COP1 mRNA, COP1 protein reached its minimum level at 24 h after UVB treatment. The p53 protein level was already increased 6 hs after UVB exposure and remained at high levels throughout the 24-h experimental period. To measure the kinetic changes in p53 mRNA expression, keratinocytes were harvested at various time points (0, 6, 12 and 24 hs) after exposure to 40 mJ/cm 2 UVB (n=3) and the p53 mRNA expression was determined by real-time RT-PCR (Fig. 11 ). In contrast with the COP1 mRNA, the p53 mRNA levels were not significantly changed during 12 hs after irradiation, but a marked increase was apparent at 24 h after UVB exposure. These results were in agreement with previously published data on the UV-induced p53 expression in keratinocytes. 
UVB irradiation alters the subcellular localization of COP1 protein in keratinocytes.
Immunofluorescence staining of COP1 demonstrated that treatment with 40 mJ/cm 2 UVB affects the subcellular distribution of the protein. Following UVB treatment, a substantial proportion of the COP1 protein was detected in the cytoplasm. This was in stark contrast with the untreated cells, in which COP1 was predominantly localized in the nucleus. However, in the cytoplasm marked perinuclear COP1 staining in the UVB-irradiated keratinocytes was apparent (Fig. 12) . Semiquantitative analysis of immunofluorescence staining demonstrated that treatment with 40 mJ/cm 2 UVB affected the COP1 expression both in the nuclei and in the cytoplasm, to approximately the same extent (Fig. 13. ).
Up-regulated p53 protein expression is further increased by UVB irradiation in gene-specifically silenced COP1 cells
Early data on COP1 expression in mammalian cells indicated that it is a critical negative regulator of p53 protein. UVB irradiation and COP1 silencing have an additive effect on the induction of p53 expression. To gain further insight into the p53 regulatory function of COP1 in keratinocytes, we determined p53 protein levels in cells in which the expression of COP1 was specifically silenced by siCOP1 RNA. Western-blot experiments revealed that the expression of shCOP1 RNA resulted in the depletion of COP1 protein and significant upregulation of p53 protein as compared with the mock-transfected cells (Fig. 14) . We next investigated the effect of UVB irradiation in siCOP1-transfected keratinocytes treated with 40 mJ/cm 2 . In these experiments, we monitored the intracellular levels of COP1 and p53 proteins 24 hs after irradiation. We demonstrated that UVB irradiation further decreased the level of COP1 protein, whereas the expression of p53 exhibited an additional increase (Fig. 14) . We concluded that COP1 silencing and UVB irradiation have additive effects on p53 protein accumulation in normal human keratinocytes.
COP1 expression in normal and UVB-irradiated human skin
COP1 protein expression was detected in normal human skin with immunohistochemistry ( Fig. 15) . COP1 expression was the most prevalent in the stratum granulosum of the epidermis, and mild positivity was also apparent in the basal layer. The staining was strongest in the cytoplasm of the epidermal keratinocytes. The expression of COP1 protein in normal human skin was also investigated by immunofluorescence labeling. In agreement with the immunohistochemistry, we found mild cytoplasmic staining in the basal layer of the epidermis and strong cytoplasmic staining was present in the granular layer (Fig. 16 ).
Figure 16.
Immunofluorescence staining of COP1 in normal human skin. Cryosections of normal human skin biopsies were labeled with polyclonal COP1 antibody: COP1 was expressed at low levels in the basal layer, and at a high level in the granular layer. Bar represents 50 µm.
Next our aim was to study the effect of UVB irradiation on COP1 expression in human skin. Normal human skin was irradiated with 2 MED and skin biopsies were taken 24 and 48 hs after irradiation (Fig. 17) . Both immunohistochemistry and immunofluorescence stainings indicated changes in COP1 expression in UVB-irradiated normal human skin. The COP1 expression was already decreased in both the stratum basale and the stratum granulosum 24 hs after the irradiation and was even lower 48 hs following the irradiation. These results suggest that the COP1 expression changes are part of the long-term stress response of human skin in response to UVB irradiation.
The level of COP1 protein in differentiating keratinocytes
The pattern of COP1 expression in the human epidermis prompted us to further analyze the changes in expression of COP1 in in vitro differentiating keratinocytes and to investigate the COP1-p53 relationship during differentiation. For the modeling of keratinocyte differentiation, we cultured keratinocytes in serum-free keratinocyte medium, with the addition of 1.7 mM calcium (Fig.18) . To monitor the differentiation of keratinocytes, the expression of involucrin, a well-known differentiation marker, was investigated through western blotting, and we found an extremely high overexpression of the protein in parallel with the aging of the culture. p53 protein was expressed at a low level in the differentiating keratinocytes and did not exhibit change with time in the experimental period. In contrast, the initiation of differentiation resulted in a definitive decrease in COP1 protein in the keratinocyte culture; this decrease was already obvious 2 days after the induction of the differentiation. In parallel with this, we detected similar changes in COP1 expression in cultured normal human keratinocytes without calcium addition: the COP1 expression displayed a gradual decrease in cultured keratinocytes (data not shown). Keratinocytes were induced to differentiate by a high calcium culture medium, harvested at the indicated time points and analyzed by western blotting for the proteins indicated. 0 d: exponentially growing cells in low calcium medium; 1-10 d: cells were cultured with a high concentration (1.7 mM) of calcium ion. The expression of involucrin, a well-characterized differentiation marker, was detected to follow the differentiation of keratinocytes in the culture.
DISCUSSION
COP1, the Constitutive Photomorphogenic Protein 1, is well conserved across species: it is essential for normal photomorphogenesis in plants (6, 7, 9) , and it has also been detected in mammalian cells (13, 15, 17, 19) . COP1 acts as a multifunctional ubiquitin ligase in plants and targets key transcription factors for proteasome-dependent degradation (8,10,15,68,69) . Oravecz et al. reported that, in stark contrast to its negative regulatory function in the visible part of the spectrum, AtCOP1 acts as a positive regulator of UVBinduced signaling in plant cells, and UVB irradiation promotes the accumulation of AtCOP1 in the nucleus (70) . These data indicate that AtCOP1 is a multifunctional E3 ligase, and both its subcellular distribution and its substrate specificity are wavelength-specific. The striking degree of structural conservation of huCOP1 with its Arabidopsis counterpart suggested the possibility of a functional similarity too (13) . Similarly to AtCOP1, MmCOP1 (13) and huCOP1 are also present in the nucleus and the cytoplasm of cells (15) . The initial characterization showed that MmCOP1 (rodent), like its plant counterpart, is indeed involved in ubiquitination and is itself a substrate of its own ubiquitination activity (15) . The huCOP1 ubiquitin ligase has been found to promote ubiquitin-dependent p53 degradation directly by the 26S proteasome (43, 45) . This process is independent of Mdm2 or Pirh2, which are also known to interact with and negatively regulate p53 (19, 31) . The expression of huCOP1 has been detected in many cell lines (19) , but its role in human cells is still not well characterized.
Our aim was therefore to investigate in detail the expression and function of huCOP1 in keratinocytes, the cell type most exposed to UVB irradiation. Our investigations showed that COP1 protein is present in human keratinocytes and immortalized HaCaT keratinocytes.
As HaCaT cells express an enormously high and stable p53 protein level carrying mutations that alter the p53 function, it was not worth while to investigate the relationship of COP1 and p53 in this cell line (71) . COP1 protein is predominantly expressed in the nucleus of keratinocytes under unstressed conditions, and milder positivity is detected in the cytoplasm.
It was previously demonstrated by others that, in an unstressed condition, p53 also shows a predominantly nuclear localization, and it is monoubiquitinated by Mdm2 (33, 45) .
Following monoubiquitination, p53 may remain in the nucleus to be polyubiquitinated by Mdm2, Pirh2, COP1 or a complex of these proteins, or it may be exported to the cytoplasm (43) . All these processes explain the high nuclear expression of COP1 protein. The nuclear export of p53 promotes its cytosolic accumulation where it is further polyubiquitinated by Mdm2, Pirh2, COP1 or a complex of these proteins and degradated in the cytosolic 26S proteasome (43) . Based on our data, we propose a potential model for COP1-p53 regulation in unstressed keratinocytes (Fig. 19) . Figure 19 . COP1 protein is present in a high amount in the cytoplasm and the nucleus of keratinocytes. In an unstressed condition, the protein functions as a ubiquitin ligase, and it results the polyubiquitination of p53, as it is well-known in plant and mammalian cells. The polyubiquitinated p53 molecule is degradated in proteasomes resulting in a low level of p53 protein.
The comparison of the COP1 mRNA levels in various human tissues revealed that the epidermis expressed a significantly lower level of COP1 mRNA than the colon or gallbladder, but it was higher as compared with the breast tissue, where it was almost undetectable. A weak COP1 signal in normal breast tissue has already been described, whereas in breast adenocarcinoma the overexpression of the protein was detected. The same was demonstrated in ovarian adenocarcinomas, where the positive COP1 signal was present only within the malignant cells, and the stromal compartment or normal ovarian tissues were negative (59). This is concomitant mainly with a decrease in steady-state wild-type p53 protein levels or p53-dependent transcription, indicating that one of the major roles of COP1 is to repress p53-dependent tumor suppression. The fact that we detected COP1 in the epidermis affirmed our aim of investigating its physiological functions in normal skin.
In order to elucidate the biological function of COP1 in the major constituent cell type of the epidermis, the keratinocytes, we investigated its expression in response to genotoxic stress such as UVB light. Although UVB light is the most prominent genotoxic stress for keratinocytes, its effect on COP1 expression has not yet been investigated in these cells.
Previously, it was shown that COP1 protein expression is decreased following ionizing treatment (IR) treatment in wild-type p53-expressing U2OS osteosarcoma cells and fibroblasts (72) . It has also been demonstrated that a decreased abundance of COP1 protein can not be attributed to a decrease in COP1 mRNA level. Short IR treatment leads to the downregulation of COP1 protein by an ATM-kinase-mediated pathway and it includes the site-specific phosphorylation of COP1 followed by auto-ubiqitination and degradation.
Another previous investigation has shown that treatment with UV irradiation results in a COP1 protein decrease in NIH3T3 mouse fibroblast cells (54) . In the present study, we found that the COP1 mRNA level exhibited a biphasic response to UVB. It was decreased early after UVB irradiation, and a slow increase was observed after 12 hs. In contrast with the biphasic mRNA profile, the COP1 protein level displayed a steady slow, but marked decrease.
In a previous study, UVC stress induced an increase in COP1 protein level in both HeLa and U2OS cells, although the COP1 mRNA showed a biphasic response characterized by a downregulation at early timepoints followed by a subsequent upregulation (58). These observations indicate that UV irradiation differentially affects COP1 protein levels in human keratinocytes and cancer cells.
Several data suggest that, besides its expression changes, the function of COP1 may also be altered by its intracellular movement (11, 15, 73) . The first data on COP1 intracellular localization revealed that UVB induces the subcellular redistribution of AtCOP1 (70) . However, in Arabidopsis thaliana, UVB increased the accumulation of AtCOP1 in the nuclei and AtCOP1 has been postulated to regulate UVB responses positively. This is in marked contrast with mammalian cells, in which the immunofluorescence staining of COP1 indicated intensive positivity, mainly in the nucleus, in the absence of UVB (11, 13, 15) . A similar subcellular redistribution of COP1 protein was also detected: ionizing radiation results in the nuclear export of COP1 protein in Flag-COP1-transfected H1299 cells, the primarily nuclear COP1 staining becoming cytosolic after IR (72) . In line with the above findings, our results showed that UVB irradiation resulted in a similar decrease in COP1 protein both in the nuclei and in the cytoplasm, and a marked amount of the protein was centered in the perinuclear region of the cytoplasm. This means that in normal keratinocytes UVB irradiation caused not only a significant decrease in the COP1 protein level, but also a notable subcellular redistribution (Fig. 20) . The most recent data on COP1 regulation suggest that, besides the above-described expression changes and intracellular movement, ataxia telangiectasia mutated (ATM) protein kinase has a critical role in the regulation of COP1 in the DNA-damage response network: in response to DNA damage, ATM phosphorylates COP1, and stimulates its rapid autodegradation. Genotoxic stress, such as ionizing radiation, promotes the auto-ubiqutination of COP1 and triggers an ATM-dependent movement of the protein from the nucleus to the cytoplasm. Finally, the auto-ubiquitined COP1 may be degraded in the cytoplasmic 26S
proteasome. This ubiquitination event appears to be entirely dependent on phosphorylation at Ser 387 , because no ubiquitination of the COP1-S387A mutant was detected: it was refractory to ATM-induced degradation (72).
COP1 is a negative regulator of p53, and the depletion of COP1 by siRNA therefore stabilizes p53: COP1 silencing resulted in a higher p53 protein level in unstressed U2OS cells (19) . In agreement with this, in our experimental set-up we saw that the depletion of COP1 by siRNA in normal keratinocytes resulted in an increase in p53 steady-state levels in unstressed conditions, indicating that COP1 has a negative regulatory role on p53 in keratinocytes too. We investigated the COP1-p53 connection in UVB-induced keratinocytes and found that the UVB irradiation of COP1-silenced keratinocytes resulted in an enhanced accumulation of p53 protein that was evident 24 h after the irradiation. COP1 silencing and UVB irradiation exerted an additive effect on p53 protein accumulation. This indicates that depletion of COP1 stabilizes p53 protein in both unstressed cells and UVB-irradiated cells and that the lack of COP1 may sensitize keratinocytes to UVB-induced cell death. Taken together, these results suggest that COP1 has an important role in the UVB response and fine tuning of apoptotic processes of keratinocytes by regulating p53.
We saw that huCOP1 contributes to the UV-induced stress response of keratinocytes.
Next, we set out to investigate whether this molecule has any role in the regulation of keratinocyte differentiation and proliferation. We found that COP1 is highly expressed in normal human skin, in both the basal and the granular layers. This suggests that COP1 may have a role in the early steps of differentiation, in which the decision occurs as to whether the basal proliferating cell will enter the proliferation program. HuCOP1 is also expressed in the granular layer of the epidermis, in cells that are in the final stages of differentiation before cell death and cornification. The pleiotropic nature of huCOP1 and its role in complex regulatory functions could be revealed when huCOP1 and p53 expressions were studied in different layers of the normal epidermis upon UVB irradiation. p53 levels are low in the normal epidermis, and its induction results in the apoptosis of proliferating keratinocytes; as keratinocytes differentiate, they become insensitive to p53-induced apoptosis (39, 48) . It is well known that UVB light induces p53 in the proliferative compartment of the basal layer, resulting in protection from the tumorigenic effects of DNA damage(49); in our experiments we detected the opposite: decreases of the huCOP1 level in both the basal and the granular layer.
Consistent with the huCOP1 staining in the epidermis, differentiating keratinocytes express COP1 in the highly proliferative stage. As keratinocytes lose their proliferation potential and begin to express differentiation markers such as involucrin, K1 and K10 Our in vitro and in vivo data suggest that huCOP1 has a role in the fine tuning of UVB response in keratinocytes via regulation of the p53 function. The high level of huCOP1 in the basal layer of the epidermis, a UV-sensitive proliferating layer, is also an important observation in our experiments, suggesting that huCOP1 has an important role and may function as an oncogene which promotes tumorigenesis in p53-expressing cells, and that interventions targeting huCOP1 could well provide new opportunities in cancer therapy.
SUMMARY
COP1 (constitutive photomorphogenic protein 1) was described in the plant Arabidopsis thaliana, as an essential negative regulator of light-mediated plant development.
COP1 also exists in non-plant multicellular organisms, although its function is less understood. The huCOP1 shows a high degree of sequence conservation and domain organization with AtCOP1, suggesting the possibility of a functional conservation as well.
The huCOP1, like its plant counterpart, is involved in ubiquitination and is itself a substrate of its own ubiquitination activity.
These investigations show that COP1 protein is present in human keratinocytes and immortalized HaCaT keratinocytes. The huCOP1 is predominantly expressed in the nucleus of keratinocytes under unstressed conditions, and a milder positivity is seen in the cytoplasm.
Human epidermis expresses significantly less COP1 mRNA than the colon or gallbladder, but markedly more than in the breast.
UVB light is the most prominent genotoxic stress for keratinocytes, but its effect on COP1 expression has not been investigated previously. In the present study, we found that the COP1 mRNA level showed a biphasic response to UVB. It decreased early after UVB irradiation, and a slow increase was observed after many hours. In contrast with the biphasic mRNA profile the COP1 protein level displayed a steady slow, but marked decrease. UVB irradiation of normal keratinocytes caused not only a significant decrease in the COP1 protein level but also a subcellular redistribution. UVB irradiation resulted in similar decreases inf COP1 protein in both the nuclei and the cytoplasm of keratinocytes and a marked amount of the protein was centered in the perinuclear region of the cytoplasm.
The depletion of COP1 by shRNA in normal keratinocytes resulted in an increase in p53 steady-state levels in unstressed conditions, indicating that COP1 also has a negative regulatory role on p53 in keratinocytes. Irradiation of COP1-silenced keratinocytes with UVB light resulted in an accumulation of p53 protein that was evident 24 h after the irradiation. COP1 silencing and UVB irradiation had an additive effect on p53 protein accumulation. This indicates that the depletion of COP1 stabilizes p53 protein both in unstressed cells and UVBirradiated cells and that the lack of COP1 may sensitize keratinocytes to UVB-induced cell death.
We found that COP1 is highly expressed in normal human skin, in both the basal and the granular layers. This suggests that COP1 may have a role in the early steps of differentiation and is also expressed in the granular layer of the epidermis, in cells that are in the final stages of differentiation before cell death and cornification. The pleiotropic nature of huCOP1 and its role in complex regulatory functions were revealed when huCOP1 and p53 expressions were studied in different layers of the normal epidermis in response to UVB irradiation. While UVB light induces p53 in the proliferative compartment of the basal layer, resulting in protection from the tumorigenic effects of DNA damage, we detected decreases in huCOP1 level in both the basal and the granular layer.
Consistent with the huCOP1 staining in the epidermis, differentiating keratinocytes express COP1 in the highly proliferative stage. As keratinocytes lose their proliferation potential, COP1 expression exhibits a gradual decrease. This decrease is not associated with any changes in the level of p53; in fact, the p53 level did not show marked changes through differentiation.
Our in vitro and in vivo data suggest that huCOP1 has a role in the fine tuning of the UVB response in keratinocytes via regulation of the p53 function. The high level of huCOP1 in the basal layer of the epidermis, a UV-sensitive proliferating layer, is also an important observation in our experiments, suggesting that huCOP1 has an important role and may function as an oncogene which promotes tumorigenesis in p53-expressing cells, and interventions targeting huCOP1 could well provide new opportunities in cancer therapy.
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